Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017. https://doi.org/10.1007/s12072-017-9799-9
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249. https://doi.org/10.3322/caac.21660. (Epub 2021 Feb 4 PMID: 33538338)
Article CAS PubMed Google Scholar
Hung AK, Guy J. Hepatocellular carcinoma in the elderly: Meta-analysis and systematic literature review. World J Gastroenterol. 2015;21(42):12197–12210. https://doi.org/10.3748/wjg.v21.i42.12197
Article PubMed PubMed Central Google Scholar
Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009;27(17):2758–2765. https://doi.org/10.1200/JCO.2008.20.8983. (Epub 2009 Apr 29 PMID: 19403886)
Cho E, Cho HA, Jun CH, Kim HJ, Cho SB, Choi SK. A Review of Hepatocellular Carcinoma in Elderly Patients Focused on Management and Outcomes. In Vivo. 2019;33(5):1411–1420
Article CAS PubMed PubMed Central Google Scholar
Hiraoka A, Otsuka Y, Kawasaki H, Izumoto H, Ueki H, Kitahata S, et al. Impact of muscle volume and muscle function decline in patients undergoing surgical resection for hepatocellular carcinoma. J Gastroenterol Hepatol. 2018;33(6):1271–1276. https://doi.org/10.1111/jgh.14058. (Epub 2018 Jan 19 PMID: 29193248)
Grimes DA. The nomogram epidemic: resurgence of a medical relic. Ann Intern Med. 2008;149(4):273–275. https://doi.org/10.7326/0003-4819-149-4-200808190-00010. (PMID: 18711159)
Tan J, Yu Y, Lin X, He Y, Jin W, Qian H, et al. OHCCPredictor: an online risk stratification model for predicting survival duration of older patients with hepatocellular carcinoma. Hepatol Int. 2023. https://doi.org/10.1007/s12072-023-10516-x
Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173–e180. https://doi.org/10.1016/S1470-2045(14)71116-7
Article PubMed PubMed Central Google Scholar
Lei Z, Li J, Wu D, Xia Y, Wang Q, Si A, et al. Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria. JAMA Surg. 2016;151(4):356–363. https://doi.org/10.1001/jamasurg.2015.4257. (PMID: 26579636)
Yang L, Gu D, Wei J, Yang C, Rao S, Wang W, et al. A Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma. Liver Cancer. 2019. https://doi.org/10.1159/000494099
Agopian VG, Harlander-Locke M, Zarrinpar A, Kaldas FM, Farmer DG, Yersiz H, et al. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients. J Am Coll Surg. 2015;220(4):416–427. https://doi.org/10.1016/j.jamcollsurg.2014.12.025. (Epub 2014 Dec 27 PMID: 25690672)
Shim JH, Jun MJ, Han S, Lee YJ, Lee SG, Kim KM, et al. Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma. Ann Surg. 2015;261(5):939–946. https://doi.org/10.1097/SLA.0000000000000747. (PMID: 24950276)
Wan G, Gao F, Chen J, Li Y, Geng M, Sun L, et al. Nomogram prediction of individual prognosis of patients with hepatocellular carcinoma. BMC Cancer. 2017;17(1):91. https://doi.org/10.1186/s12885-017-3062-6
Comments (0)